Katja Kiseljak-Vassiliades, DO

University of Colorado School of Medicine and Research Service VAMC, United States

Disclosure information not submitted.

Presentation(s):

• ORF13-06 - Integrated Genomics, Steroidomics and High Throughput Drug Screening in a New Adrenal Cancer Cell Line (CU-ACC327) and Patient Derived Xenograft (PDX): Impact on Personalized Treatment

  Saturday, June 13, 2026
  2:30 PM - 2:45 PM CT